Eloxx Pharmaceuticals
ELOX18.4300.11% ( -0.020 )
Eloxx Pharmaceuticals (ELOX)
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readt...
- Open
- 18.440
- High
- 19.100
- Low
- 17.500
- Prev. Close
- 18.450
- Volume
- 44.61K
- Turnover
- 818.28K
- Avg Price
- 18.342
- Bid/Ask Ratio
- --
- Amplitude
- 8.67%
- 52wk High
- 19.358
- Volume Ratio
- 0.32
- Turnover Ratio
- 2.45%
Eloxx Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$41.50125.18%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · 22 hours ago
Biotech Stocks At 52-Week Highs - ANGO, ANIK, ELOX, YARW, PLSE
- Price Alert · 1 day ago, 08:15 AM
Pre-market hot trades in US stocks: Eloxx Pharmaceuticals up 9.06% in pre-market; Lumentum down 3.49% in pre-market
- Global Report · Jul 28 at 04:13 AM
Backblaze Strikes $335 Million AI Deal as Periphery Equities Target Second-Half Commercial Milestones
- Global Report · Jul 21 at 04:13 AM
The Market's Misfits: Who is Faking It and Who is Building the Future?
- Global Report · Jul 19 at 04:13 AM
The Great Biotech Reckoning: When AI and Gene Editing Meet Wall Street's Patience in 2026
- Global Report · Jul 18 at 04:13 AM
Beyond the Averages: What a Random Cross-Section of US Equities Tells Us About the 2026 Economy
